Data analysis
All statistical analyses were performed with the use of SPSS statistics (version 18.0; Statistical Package for the Social Sciences Inc., Chicago, IL, USA). Continuous variables are expressed as mean± standard deviation. The comparison of discrete variables was done using Fisher's exact test and the comparison of means was done using the unpaired Student's t-test. Long-term adverse cardiac event were analyzed using Kaplan-Mayer survival analysis. A 2-tailed p of <0.05 was considered to be statistically significant.
Results

Demographic characteristics of patients with acute aortic syndrome
As of September 2006, 528 patients were enrolled. Mean patient age was 60.05±14.51 years-old and there were more males (56.3%) enrolled. About two-thirds (n=350, 66.3%) of patients were referred from other hospitals, where the surgical approach was not capable. The components of AAS were as follows: acute AD (n=446, 84.5%), IMH (n=57, 10.7%), PAU (n=11, 2.1%) and the other (n=14, 2.6%). As risk factors of AAS, a considerable number of patients were current smokers (n=123, 57.5%) and the duration of smoking was 26.8±12.9 pack-years. The percentage of patients with diabetes was 10.6% (55 subjects). Although small in proportion, there were other risk factors, such as coronary artery disease (n=17, 3.2%), cerebrovascular disease (n=17, 3.2%), and peripheral artery disease (n=2, 0.4%) etc. Interestingly, previous history showed that 8 .3% (44) of the patients also had family history of AAS. Among its etiologies, hypertension was the most prevalent (n=371, 70.3%) and the rest were like this: atherosclerosis (n=65, 12.3%), Marfan syndrome (n= 21, 4.0%), trauma (n=14, 2.7%), cardiac catheterization (n=6, 1.1%), cardiac surgery (n=4, 0.8%), and pregnancy (n=2, 0.4%).
For the symptomatology, two thirds of patients presented with acute chest pain (n=394, 76.4%) within several hours, and among these patients, half of the patients had abrupt onset of pain (55.7%) on the same region. Migrating chest pain, moving from one region to another was also noted (16.7%). Other accompanied findings were pericardial effusion (on echocardiogram, 7.8%), pleural effusion (on chest X-ray, 4.4%), syncope (transient loss of consciousness, 4.0%), shock { systolic blood pressure (BP) <100 mm Hg, 3.2% } , neurologic deficit (weakness/paralysis of limb, impaired hearing/vision/ speech, or loss of sensation, 2.8%), loss of consciousness (lasts more than 3 seconds, 2.8%), symptoms of heart failure (dyspnea/orthopnea/dyspnea on exertion, 1.5%) and presence of an aortic regurgitant murmur (on auscultation, 1.5%).
Diagnosis and treatment modality in patients with acute aortic syndrome
Approximately half of the patients had normal findings on chest X-ray (43.2%). One-third (34.8%) of patients had a widened mediastinum was only, the remaining patients had abnormal aortic contour (5.3%) and miscellaneous findings (lung or cardiac lesion, 16.7%). On electrocardiogram, two-thirds (61.0%) of the patients showed normal findings, however 17.6% showed ST-segment deviation (either horizontal elevation or depression more than 1 mm at 2 or more leads) and 21.2% showed non-specific ST-T changes. There showed no increased incidence of ST-segment deviation in patients with either coronary involvement or shock at presentation (data not shown).
The most popular diagnostic modality for AAS was CT (92.4%, 488), whereas transesophageal echocardiogram (8.1%), aortogram (4.5%) and magnetic resonance imaging (1.1%) were also performed in some institutions for the same purpose.
The AAS can be classified using well-established DeBakey and Stanford classifications. In terms of DeBakey classifications, there were class I (30.3%), class II (9.1%) and class III (60.6, most prevalent). In Stanford classifications, however, prevalence of Stanford A was a little less than Stanford B (45.6% vs. 54.4%). For the overall treatment modality, medical treatment was more than half (55.7%), and surgical (40.0%) or endovascular (4.3%) treatment were performed as well.
Comparison of aortic dissection and intramural hematoma
Because of the missing variables on CRF, the data from 452 patients among entire 528 patients were divided into AD (n=402) and IMH (n=50). There were no significant differences between AD and IMH group in terms of smoking status, hypertension, and dia- (Table 3) . In terms of AAS classifications, the percentage of Stanford A and B were similar in AD group (53.2% vs. 46.8%), whereas the percentage of Stanford B was predominant in IMH group (A: 2.0% vs. B: 98.0%). For the definitive treatment modality, the patients with AD underwent more surgical therapy than IMH patients (47.3% vs. 8.0%, p<0.001), whereas the patients with IMH was mainly treated conservatively than AD patients (86.0% vs. 48.5%, p<0.001). For the type of surgery, ascending aortic replacement was more frequently performed in AD than IMH group (34.8% vs. 6.0%, p<0.001), but in other types, there were no differences ( Table 5 ). All the patients with IMH underwent surgery (n=4) were Stanford type A lesion. Among them, 3 patients had cardiac tamponade and 1 patient had coronary artery involvement of hematoma. All 4 patients underwent ascending aortic replacement and there were no complications regarding surgery (data not shown).
The percentage of required stay in the coronary care unit (CCU) was significantly higher for patients in the AD group rather than in the IMH group (79.1% vs. 66.0%, p=0.031). The prescription rate of beta-blockers, calcium-channel blockers, as well as intravenous nitroprussides were higher in IMH group than AD group, respectively (78.0% vs. 59.7%, p=0.008; 48.0% vs. 31.8%, p=0.018; 56.0% vs. 39.1%, p=0.017) ( Table 3 ). The patients with IMH showed less inhospital complications than those with AD (8.0% vs. 22.4%, p=0.010). In addition, there were no reported in-hospital death in IMH group, whereas 9.2% of patients in AD group died during hospital stay (p=0.011) ( Table 4) .
Comparison of type A and type B aortic dissection
The AD group was divided further into type A AD (n=214) and type B AD (n=188) and compared. For the type of surgery, type A group of patients underwent ascending aortic replacement, complete arch replacement and root replacement in the order of frequency, but incidence of all types of surgery is higher than type B. Accordingly, there showed higher incidence of CCU stay in type A than type B (87.9% vs. 69.1%, p< 0.001). For medications, only beta-blocker was more highly used in type B than type A group (69.1% vs. 51.4%, p<0.001) ( Table 5) .
In terms of in-hospital complications, its incidence was higher in type A than type B (27.6% vs. 16.5%, p=0.005). Occurrences of inhospital death, as well as cardiac tamponade were also significantly higher in type A than type B group of patients (13.1% vs. 4.8%, p= 0.003; 2.3% vs. 0.0%, p=0.042, respectively) ( Table 6 ).
The patients in type A group, who were not treated surgically (i.e., conservatively, n=40) seemed to have less incidence of complications, such as cardiac tamponade (2.0%), neurologic deficit (2.0%), myocardial infarct (0%), limb ischemia (2.0%) and acute renal failure (3.9%). The diameter of ascending aorta (4.96±1.19 cm), the length of total involved segment (8.73±7.30 cm), the duration of CCU stay (4.59±3.27 days) seemed to be short. The incidence of inhospital complication was similar to overall type A group (27.3% vs. 27.6%).
On the other hand, the patients in type B group, who were treated surgically, seemed to have rather higher incidence of complications, which were neurologic deficit (5.9%), myocardial infarct (5.9%), limb ischemia (2.0%), mesenteric infarct (5.9%), and acute renal failure (11.8%). The diameter of ascending aorta seemed to be normal (3.70±0.48 cm) and the length of total involved segment was also short (7.27±5.37 cm). However, the duration of CCU stay was a bit longer than the overall type B group (9.14±7.60 vs. 6.06±4.96). On laboratory data, serum BUN, Cr, aspartate aminotransferase (AST)/ alanine aminotransferase (ALT) levels were all elevated (22.1±28.8, 
Long-term clinical outcome in patients with acute aortic syndrome
The long-term clinical follow-up was available only in 179 patients out of entire population. All the patients followed were those with Ads (type A-96 patients, type B-83 patients). Clinical and imaging follow-up duration was 42.8±36.3 months, 9.8±3.4 months, respectively. Total major adverse cardiac events (death, stroke, myocardial infarct, surgery/endovascular treatment, exacerbation of renal function) occurred in 41 patients (22.9%) and 18 patients died (10.1%) during this period. There showed trends toward shorter event-free survival for type A group than type B group (9.6±4.9 vs. 18.1±5.1 months, p=0.059). The death-free survival was significantly shorter in type A group than type B group (6.9±6.6 vs. 20.8± 9.3 months, p=0.015) (Figs. 1 and 2 ).
Discussion
The term AAS, coined by Vilacosta and associates in 1998, refers to a heterogeneous group of conditions that cause a common set of signs and symptoms, the foremost of which is aortic pain.
1) Various diseases may cause this striking presentation, including trauma, pseudoaneurysm, and ruptured atherosclerotic aneurysm, but the term has come to subsume AD, intramural hematoma (IMH) and PAU. 6) Despite its appearance in the literature a decade ago, there have been few reports on evaluating its nature, as well as its clinical significance. In this study, we sought to demonstrate the clinical picture of this entity in Korean patients, by the collaborative efforts of making AAS multicenter registry and we believe, to our knowledge, this report is the first in this regard. In the literature, the international registry of acute aortic dissection (IRAD) was the first multicenter experience of collecting data in patients that had acute AD, a major component of AAS. In that registry, 12 international referral centers enrolled the data. This IRAD gave the idea of creating the Korean AAS registry.
The typical patient in IRAD registry was a male in his seventh decade with a history of hypertension who presents with abrupt onset of chest pain.
7)8) In our registry, the clinical characteristics were slightly similar with IRAD: mean age 60 year-old, over 70% of the patients have hypertension and acute chest pain, as presenting symptoms. It might be explained that about three quarter of patients were having ADs in our registry, which make the clinical charac- teristics\similar to that of IRAD. However, unlike IRAD, the percentage of females was similar to that of males, suggesting that Korean female patients were more frequently affected by AAS than those in the Western countries. Classically, the earlier studies emphasized the value of abnormal chest X-ray findings, among them most popular one is widened mediastinum.
8)9) In our registry, about a half of the patients did not showed any evidence of mediastinal widening, which suggests that chest X-ray could not be used alone as a screening purpose for patients with AAS. As expected, the CT was the imaging modality of choice in nearly all patients (92.4%). On the contrary, aortogram and TEE, which was frequently used before, were rarely utilized as initial diagnosis.
For the treatment of AD (type A and B), overall in-hospital mortality has been reported as 27.4% in IRAD registry.
2) In our study, overall in-hospital event rate was 21.1% and mortality was only 8.2% in all patients with AAS. In addition, over 80% of the patients in IRAD underwent surgery and the patients who had not underwent surgery has a other condition such as extreme age (over 80 years old) and serious comorbidity. On the contrary, our registry included patients with IMH, who are believed to have lower event rates and the number of type B dissections were similar to that of type A. In addition, unlike IRAD patients, only half of the patients in our registry underwent surgery as a definitive treatment. As we can confer from these results, the patients with different characteristics translated into a better in-hospital outcome.
It is interesting to note that the mean systolic/diastolic BP was significantly higher in IMH group than AD group, as well as type B AD group than type A AD group. Even though the BP itself in both groups was above shock range (over 100 mm Hg), the difference in BP have probably influenced the more usage of anti-hypertensive medications (especially beta-blocker and calcium channel blocker) in the former groups than the latter groups, which might have affected patient outcome to certain degree.
The decline in renal function, as demonstrated by higher level of BUN and Cr in AD group than IMH group from our registry can be explained by several causes: higher incidence of type A lesions, a higher incidence of hypotension/shock, and possibly increased renal artery involvement.
Comparison between type A and type B dissections had interesting results. For type A, two-thirds (75.7%) of the patients underwent surgery, whereas for the type B, more than two-thirds (78.7%) of the patients were treated with medicine; this can be demonstrated as approximately equal to 50% of the rate of surgery and medical management among the AD population in our study.
There were several single center reports on the surgical management of type A AD. According to the report by Cho et al. 10) which showed the outcome of 28 patients after aortic arch replacement for type A AD, the hospital mortality after surgery was 3.6% and inhospital neurologic complication was 17.9%. During the 26-month follow-up, 10.7% of patients underwent reoperation due to aortic aneurysm formation, but there was no late death. In another recent report by Campbell-Lloyd et al. 11) they reported on 65 patients with acute type A AD that had undergone surgical repair. In that report, full arch replacement was performed in 14% of patients and concomitant coronary artery bypass graft was performed in 11%. Postoperative neurologic dysfunction was present in 33.8% of patients and only significant predictor of poor neurologic outcome was full arch replacement. In our registry, the percentage patients underwent complete arch replacement for type A AD was similar to the reports by Campbell-Lloyd et al. 11) (14% vs. 13.6%), but interestingly enough the rate of neurologic complication was as low as 2.3%. The reason why might be due to several factors: different patient demographics, concomitant disease, the timing of surgery and the surgical skill of operators each hospital. In contrast to the traditional guidelines, there were patients with type A AD treated conservatively, as well as those with type B AD treated surgically. In our registry data shown in the result, the former group of patients had fewer complications in aortic root, arch, and comorbid conditions (acute renal failure, mesenteric infarct etc.). But, the rate of in-hospital complications was similar to the overall type A AD group, suggesting that although the patient had type A AD, if there were no or little root or arch-related complications, then we could choose medical therapy for the first strategy. The latter group of patients had a little higher incidence of complications regarding the flow compromise to the aortic branch vessels, such as mesenteric infarct, acute renal failure, as well as higher serum levels of BUN/Cr, AST/ALTs, which necessitated use of the surgical option. Because the patients in this group underwent surgery as a bail-out strategy, it seems a matter of course that the rate of in-hospital complications was higher than those with overall type B group, as shown in our registry data. For the treatment of IMH, over 80% of the patients were treated medically and only 8% underwent surgery. The IMH has been recently recognized as a unique disease entity with pathological and clinical features different from classic AD. [12] [13] [14] [15] [16] There are many reports that IMH is also regarded as a similar entity to classic AD in terms of disease progression and it should be treated, as similar to AD. In our registry data however, the majority of IMH patients were type B, which might be strong explanation for the large percentage of patients having received initial medical treatment. It is interesting to note that few selected patients with IMH who underwent surgery had aortic root involvement in our registry data (n=4). As we mentioned before, 3 patients had cardiac tamponade and 1 patient had coronary artery involvement of mural hematoma, suggesting that even though IMH has a favorable prognosis, surgical therapy should be considered if the patient had aortic root involvement. Endovascular treatment is regarded as a well-established option for the treatment of AD. Even though total number of endovascular treatment was small, patients with type B underwent more frequently than those with type A (6.4% vs. 0.9%). Because of the recent development of endovascular equipment, among them are sophisticated stent grafts from many companies, the number of endovascular treatment certainly be increased over time. In Korea, Kang et al. 19) reported the early experiences of stent graft implantation in Standford type B AD among 28 patients. In that report, clinical success rate was as high as 96.4% and there were no reported mortality regarding the procedure, as well as no mortality afterwards during 22.1 months' follow-up. A recent report by Botsios et al. 20) showed the outcome of endovascular treatment for 32 patients presented with complicated acute type B dissection. In that report, the procedure was successful in all patients and in-hospital mortality seemed to be acceptable (9.3%). Although the number of patients with type B AD included in our data was relatively small (12 patients), all of the the subjects underwent successful endovascular treatment without in-hospital complications (data not shown).
In terms of vascular inflammation affecting AAS outcome, there were few reports. Lee et al. 21) reported the outcome of 81 medicallytreated type B AD patients in regard to the level of vascular inflammation. In that report, they demonstrated that a high monocyte count (>1250/mm 3 ), high level of high-sensitivity C-reactive protein (hsCRP, >11 mg/dL) and D-dimer (>1.2 mg/dL) as a independent determinant of short-term mortality. In our data, the mean hsCRP for AD and IMH were 14.45 and 14.85, all of which were above cut-off applying the data by Lee et al. 21) Based on that, our findings simply suggests that serum hsCRP level seemed to be high in patients with AAS, but it is uncertain whether hsCRP is an independently significant predictor of a poor outcome event or not.
Study limitations
There are several limitations associated with the analysis of our data. This was a multicenter registry and thereby has inherent limitations. First, because the patients were enrolled by retrospective review of medical records, selection bias might be introduced from the beginning of enrollment. Also, many patients were dropped from the analysis between each groups due to missing variables on CRF, this may have inserted further selection bias. Second, the treatment outcome of surgery is largely dependent upon the technical expertise of each operator in each hospital. So, this should be taken into consideration while analyzing the data. Third, the treatment strategy for each type AAS might be also different in each hospital (for instance, the one hospital prefer to treat medically for uncomplicated type B AD, while other prefer to perform surgery etc.). So, it is often difficult to judge one type of treatment is better than the other. Fourth, because the long-term data were only obtainable from the selected AD group, the survival analysis cannot reflect the whole AAS registry patients.
In conclusion, AAS is a group of heterogeneous diseases that have different natural history and different clinical course. By organizing real-world multicenter registry of AAS, we could demonstrate diverse features, as well as clinical impact of this rare entity in Korean patients. Further, a large-sized prospective study is warranted.
